EVM
MESO

Eaton Vance Management’s Mesoblast MESO Stock Holding History

Eaton Vance Management’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50
Closed – – 2353
2021
Q4 		$0 Hold
50
– – ﹤0.01% 2854
2021
Q3 		$0 Hold
50
– – ﹤0.01% 2421
2021
Q2 		$1K Buy
+50
New +$785 ﹤0.01% 2765

Other funds holding MESO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
TFA
Tobias Financial Advisors Plantation, Florida $718M AUM 15.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSTAM
Wilbanks Smith & Thomas Asset Management Norfolk, Virginia $3.57B AUM 21.11% 1-Year Est. Return

Eaton Vance Management's MESO Position: Q1 2022 in Review

Eaton Vance Management sold out of Mesoblast (MESO) in Q1 2022, closing a stake of 50 shares.

Eaton Vance Management first reported a position in MESO in Q2 2021 and held it in 3 quarters. The position peaked at $1K in Q2 2021. 37 funds tracked by Wall St. Rank hold MESO as of Q1 2022.

  • Eaton Vance Management reported no remaining Mesoblast position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 50 Mesoblast shares in Q1 2022.
  • Eaton Vance Management first reported a position in Mesoblast in Q2 2021 and held it in 3 quarters.
  • Eaton Vance Management's Mesoblast position peaked at $1K in Q2 2021.
  • 37 funds tracked by Wall St. Rank held Mesoblast as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.